EUVIMEDEUVIMED entdecken
Open Access

POSTN + CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy

Zhenhua Zhu, Kangnan Zhang, Wei Wu, Jingyi Zhou, Mingming Zhang, Jiong Chen, Jinlu Han, Na Wang, Biao Li, Wenhao Weng, Qinghui Zhang, Min Zhou und 1 weitere

Research · 2025-01 · 8

DOI: 10.34133/research.0950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research, online erschienen am 22.10.2025. Verfasst von Zhenhua Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-associated fibroblasts (CAFs) are known to shape the tumor microenvironment, yet the role of extracellular vesicles they produce, particularly migrasomes, in hepatocellular carcinoma (HCC) remains largely unexplored. In this study, we identified a subset of POSTN + CAFs as the main source of migrasomes in HCC, predominantly located at the tumor–stroma interface. Transcriptomic data from TCGA and ICGC were used to compute a Migrasome_Score via GSVA, revealing strong associations with poor prognosis and immune checkpoint blockade resistance across cancers. Mechanistically, POSTN + CAF-derived migrasomes enhanced endothelial angiogenic activity by delivering VEGFA and activating the VEGFR2–PI3K–AKT–eNOS pathway, promoting vascular remodeling within tumors. Migrasomes also induced malignant reprogramming of nearby hepatocytes by boosting oxidative phosphorylation and reactive oxygen species (ROS) production, leading to DNA damage and oncogenic transformation—effects reversed by ROS scavenging. Additionally, POSTN + CAFs and their migrasomes physically hindered immune cell infiltration, forming a barrier that shielded tumor cells from immune surveillance. Together, these findings identify POSTN + CAF-derived migrasomes as key drivers of HCC progression by promoting angiogenesis, malignant transformation, and immune exclusion. Their strong links to poor prognosis and immunotherapy resistance suggest that they may serve as promising therapeutic targets and prognostic biomarkers in HCC and beyond.

Autor:innen und Institutionen

  • Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
  • Department of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China.
  • Clinical Research Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
  • School of Artificial Intelligence and Data Science, University of Science and Technology of China, Hefei 230000, China.
  • Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
  • Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

ORCID-Profile: Ling Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Z., Zhang, K., Wu, W., Zhou, J., Zhang, M., Chen, J., Han, J., Wang, N., Li, B., Weng, W., Zhang, Q., Zhou, M., & Xu, L. (2025). POSTN + CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy. Research, 8. https://doi.org/10.34133/research.0950

Vancouver

Zhu Z, Zhang K, Wu W, Zhou J, Zhang M, Chen J, et al. POSTN + CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy. Research. 2025;8. doi:10.34133/research.0950

BibTeX
@article{Zhu2025,
  author = {Zhu, Zhenhua and Zhang, Kangnan and Wu, Wei and Zhou, Jingyi and Zhang, Mingming and Chen, Jiong and Han, Jinlu and Wang, Na and Li, Biao and Weng, Wenhao and Zhang, Qinghui and Zhou, Min and Xu, Ling},
  title = {POSTN + CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy},
  journal = {Research},
  year = {2025},
  volume = {8},
  doi = {10.34133/research.0950}
}
Kostenlos starten →